The Importance Of Filter Testing - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

The Importance Of Filter Testing

Pharmaceutical Technology Europe
Volume 23, Issue 8

How important is filter testing in the pharma industry?

Graham Rideal
Filtration in the pharmaceutical industry covers a wide range of applications from powder processing to liquid purification, such as saline or dextrose solutions. In the case of the former, the advantage of good filtration processes mainly lies in recovering valuable drugs, which can cost in excess of $1 million per kilogram. The advantage here is purely commercial.

For intravenous products, however, good filtration is a matter of life and death; a simple internet search on recalled drugs reveals particulate contaminants from the clearly visible, such as glass fragments, wood fibres and mould, to the invisible, and potentially lethal, bacteriological contamination.

The primary test of a filter begins with the filter medium itself to ensure it is fit for purpose. Thereafter the filter system must be tested in situ. Failure can occur in the filter medium or in the sealing arrangement when assembled.


One of the simplest methods of comparing filter media is to test porosity either by air or water flow under prescribed conditions. Lower flow rates or higher back pressures indicate better filter performance.

Bubble point

The flow rate method is refined in the so-called bubble point test. Here, the filter is saturated with a liquid and then a gas (usually air) is pressurised from below. As the pressure increases, the air finds the single largest pore, which is blown out, forming a bubble on the surface: the bubble point. The Washburn equation is then applied to convert the applied pressure into the diameter of the pore.


Porometry takes the bubble point one step further by continuing the pressurisation of the filter beyond the bubble point. Successively smaller pores are blown clear by the air pressure until the smallest pore is finally evacuated. The applied pressure versus flow rate profile can then be interpolated to provide complete pore size distribution.


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Source: Pharmaceutical Technology Europe,
Click here